INR 750.9
(-0.05%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 3.66 Billion INR | 1.32% |
2022 | 3.62 Billion INR | 3.49% |
2021 | 3.49 Billion INR | 27.56% |
2020 | 2.74 Billion INR | 33.57% |
2019 | 2.05 Billion INR | 9.45% |
2018 | 1.87 Billion INR | 13.04% |
2017 | 1.65 Billion INR | 2.0% |
2016 | 1.62 Billion INR | 15.87% |
2015 | 1.4 Billion INR | 13.35% |
2014 | 1.23 Billion INR | 3.02% |
2013 | 1.2 Billion INR | -3.13% |
2012 | 1.24 Billion INR | -13.47% |
2011 | 1.43 Billion INR | -8.6% |
2010 | 1.56 Billion INR | 32.66% |
2009 | 1.18 Billion INR | 6.92% |
2008 | 1.1 Billion INR | 129.78% |
2007 | 481.66 Million INR | 16.28% |
2006 | 414.23 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q3 | - INR | -100.0% |
2023 Q4 | 3.66 Billion INR | 0.0% |
2023 FY | 3.66 Billion INR | 1.32% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 3.55 Billion INR | 0.0% |
2022 Q4 | 3.62 Billion INR | 0.0% |
2022 FY | 3.62 Billion INR | 3.49% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 3.68 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 Q4 | 3.49 Billion INR | 0.0% |
2021 Q2 | 3.1 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 3.49 Billion INR | 27.56% |
2021 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 2.74 Billion INR | 0.0% |
2020 FY | 2.74 Billion INR | 33.57% |
2020 Q1 | - INR | -100.0% |
2020 Q2 | 2.45 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 1.99 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q4 | 2.05 Billion INR | 0.0% |
2019 FY | 2.05 Billion INR | 9.45% |
2018 Q1 | - INR | -100.0% |
2018 FY | 1.87 Billion INR | 13.04% |
2018 Q4 | 1.87 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 1.65 Billion INR | 0.0% |
2017 FY | 1.65 Billion INR | 2.0% |
2017 Q2 | 1.58 Billion INR | 0.0% |
2017 Q4 | 1.65 Billion INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2016 FY | 1.62 Billion INR | 15.87% |
2016 Q4 | 1.62 Billion INR | 0.0% |
2015 FY | 1.4 Billion INR | 13.35% |
2014 FY | 1.23 Billion INR | 3.02% |
2013 FY | 1.2 Billion INR | -3.13% |
2012 FY | 1.24 Billion INR | -13.47% |
2012 Q2 | 2.89 Billion INR | 0.0% |
2012 Q4 | 1.24 Billion INR | 0.0% |
2011 FY | 1.43 Billion INR | -8.6% |
2010 FY | 1.56 Billion INR | 32.66% |
2009 FY | 1.18 Billion INR | 6.92% |
2008 FY | 1.1 Billion INR | 129.78% |
2007 FY | 481.66 Million INR | 16.28% |
2006 FY | 414.23 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Sigachi Industries Limited | 6.94 Billion INR | 47.149% |
Ind-Swift Limited | 6.54 Billion INR | 43.944% |
Bajaj HealthCare Limited | 7.65 Billion INR | 52.051% |
Sakar Healthcare Limited | 3.88 Billion INR | 5.606% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.186% |
Innova Captab Limited | 13.2 Billion INR | 72.225% |
Divi's Laboratories Limited | 154.7 Billion INR | 97.629% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 65.968% |
Morepen Laboratories Limited | 12.93 Billion INR | 71.631% |
Mankind Pharma Limited | 119.63 Billion INR | 96.933% |
Sequent Scientific Limited | 15.4 Billion INR | 76.183% |
Wanbury Limited | 3.43 Billion INR | -6.806% |
Laurus Labs Limited | 83.87 Billion INR | 95.626% |
Nectar Lifesciences Limited | 21.91 Billion INR | 83.256% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 87.129% |
Alembic Limited | 23.28 Billion INR | 84.246% |
Hikal Limited | 24.87 Billion INR | 85.249% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 94.308% |
Neuland Laboratories Limited | 18.32 Billion INR | 79.98% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 90.815% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 97.445% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 83.654% |
Themis Medicare Limited | 5.66 Billion INR | 35.23% |
RPG Life Sciences Limited | 5.12 Billion INR | 28.467% |
Zydus Lifesciences Limited | 292.8 Billion INR | 98.747% |
Lupin Limited | 239.97 Billion INR | 98.471% |
Wockhardt Limited | 76.49 Billion INR | 95.204% |
Vaishali Pharma Limited | 799.55 Million INR | -358.842% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 85.792% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -69.004% |
Jubilant Pharmova Limited | 115.48 Billion INR | 96.823% |
FDC Limited | 24.68 Billion INR | 85.135% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.053% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -52.824% |
Eris Lifesciences Limited | 70.48 Billion INR | 94.795% |
Venus Remedies Limited | 6.26 Billion INR | 41.472% |
ZIM Laboratories Limited | 4.46 Billion INR | 17.893% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 69.777% |
Par Drugs and Chemicals Limited | 1.01 Billion INR | -261.054% |
Caplin Point Laboratories Limited | 26.97 Billion INR | 86.399% |
Shilpa Medicare Limited | 30.93 Billion INR | 88.139% |
Albert David Limited | 4.97 Billion INR | 26.33% |
Ajanta Pharma Limited | 46.38 Billion INR | 92.091% |
Hester Biosciences Limited | 6.62 Billion INR | 44.61% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 83.724% |
Solara Active Pharma Sciences Limited | 23.46 Billion INR | 84.366% |
Gufic Biosciences Limited | 10.92 Billion INR | 66.42% |
Windlas Biotech Limited | 6.26 Billion INR | 41.414% |
Procter & Gamble Health Limited | 7.94 Billion INR | 53.816% |
Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -20.289% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -10.031% |
Granules India Limited | 55.2 Billion INR | 93.355% |
Aarti Drugs Limited | 24.32 Billion INR | 84.917% |
Bal Pharma Limited | 3.2 Billion INR | -14.508% |
Alkem Laboratories Limited | 155.74 Billion INR | 97.644% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.571% |
Lincoln Pharmaceuticals Limited | 7 Billion INR | 47.612% |
Medicamen Biotech Limited | 2.94 Billion INR | -24.565% |
Unichem Laboratories Limited | 31.69 Billion INR | 88.424% |
Bafna Pharmaceuticals Limited | 1.47 Billion INR | -148.42% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -679.205% |
Valiant Laboratories Limited | 3.42 Billion INR | -7.057% |
Orchid Pharma Limited | 15.53 Billion INR | 76.39% |
Medico Remedies Limited | 961.95 Million INR | -281.381% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 68.512% |
Ipca Laboratories Limited | 111.01 Billion INR | 96.695% |
Brooks Laboratories Limited | 904.45 Million INR | -305.627% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 9.339% |
Piramal Enterprises Limited | 826.05 Billion INR | 99.556% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 97.564% |
NATCO Pharma Limited | 69.06 Billion INR | 94.688% |
Suven Life Sciences Limited | 2.84 Billion INR | -28.771% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -105.905% |
Strides Pharma Science Limited | 58.39 Billion INR | 93.718% |
Indoco Remedies Limited | 21.44 Billion INR | 82.894% |
Alpa Laboratories Limited | 1.82 Billion INR | -100.891% |
Lasa Supergenerics Limited | 1.5 Billion INR | -143.172% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 28.769% |